Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$8.07
-0.11-1.34%
Last update: Oct 22, 4:16 PM
$8.00
-0.18-2.2%
Kazia Therapeutics Ltd (KZIA) Stock Price, Quote, News & History
KZIANASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Kazia Therapeutics (NASDAQ:KZIA) through any online brokerage.
Other companies in Kazia Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Kazia Therapeutics has a consensus price target of $27.11.
The stock price for Kazia Therapeutics (NASDAQ: KZIA) is $8 last updated October 22, 2026 at 4:16 PM EDT.
There are no upcoming dividends for Kazia Therapeutics.
Kazia Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Kazia Therapeutics.
Kazia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
